Writing on product systems, fintech infrastructure, market behavior, and leadership lessons from practical execution.
📚 Books
Beyond platform leadership and infrastructure design, I write about trading psychology, financial literacy, and structured market participation.
Both books are published globally on Amazon (Kindle & Paperback editions available).
🟦 The Mind Game of Trading
Mastering Psychology for Consistent Profits
By Sreenivasulu Malkari

Overview
Trading success is rarely limited by strategy. It is limited by psychology.
In The Mind Game of Trading, I distill 15+ years of real-world trading experience into a structured framework for mastering discipline, emotional control, and execution integrity.
The book focuses on:
• Identifying hidden cognitive biases
• Structured journaling & checklist systems
• Emotional risk management
• Practical trading plan templates
• Long-term consistency frameworks
This is not a theory book — it is a practical discipline manual for traders at all levels.
🔗 Available on Amazon (Paperback & Kindle)
👉 https://www.amazon.com/dp/B0FNKGB7W2
🟦 The Stock Market Starter Kit
Learn to Trade Smart in 7 Days
By Sreenivasulu Malkari

Overview
Designed for beginners entering the Indian stock market, this book simplifies complex concepts into a structured 7-day learning framework.
It emphasizes structured thinking, capital protection, and long-term consistency as the core pillars of intelligent market participation.
It covers:
• How stock markets function (NSE/BSE context)
• Intraday, swing & long-term trading basics
• Risk management principles
• Chart reading fundamentals
• Practical checklists and action plans
Clear. Structured. Actionable.
🔗 Available on Amazon (Paperback & Kindle)
👉 https://www.amazon.com/dp/B0FF2NK8MV
-
“LG Electronics India IPO Review: Opportunities, Risks, and Strategy”
Why Everyone Is Talking About the LG IPO Imagine this: you’re sipping your morning chai, scrolling through the markets section, and one headline catches your eye — “LG Electronics India to launch Rs 15,000 crore IPO in October 2025.” The buzz around the stock market has suddenly intensified. Why? Because when a brand as big…
-
“Trump’s 100% Pharma Tariff: What It Means for Indian Pharma Drugmakers”
Explore the implications of President Trump’s 100% tariff on branded drugs for Indian pharmaceutical companies like Sun Pharma, Cipla, and Dr. Reddy’s. In a bold move that has sent ripples through the global pharmaceutical industry, President Donald Trump announced a 100% tariff on imported branded and patented drugs, effective October 1, 2025. This decision has…
-
“Tax Audit Deadline Extended: What You Need to Know”
The CBDT has extended the tax audit report filing deadline to October 31, 2025. Learn what this means for you and how to comply with the new deadline. If you’re a business owner, professional, or entrepreneur in India, the Income Tax Audit Report (TAR) deadline extension to October 31, 2025, is a crucial development you…
-
Amul Price Cut 2025: 700+ Products Cheaper from Sept 22 – Full List Inside
Relief in the Air and on the Plate Festive season is when Indian households stretch their budgets the most—new clothes, sweets, gifts, and of course, that extra stock of butter, ghee, and ice cream in the fridge. But rising prices often turn this excitement into anxiety. That’s why the latest Amul price cut on 700+…
-
“Buy-on-Dips Strategy Explained: Using Nifty Support at 25,300 & VIX for Smarter Trades”
“Near-term support lies at 25,300 & 25,150 while resistance is 25,500 — here’s how to trade Nifty using ‘buy-on-dips’, India VIX cues & resistance breakout strategy.” Ever felt stuck wondering “Where will Nifty move next?” You’re not alone. One day it seems ready to leap, the next day it’s testing its nerve around key levels.…
-
“BSE under Threat? Jefferies Warns of 20-50% EPS Cuts in New Expiry Scenarios”
How will SEBI’s proposed expiry changes impact the BSE share price? Jefferies lays out four scenarios and potential earnings drops — what investors need to know. Imagine you own a piece of a company whose revenues depend heavily on how often people trade options. Now imagine the regulator changes when those expiries happen — from…